5 Point Guide to New Therapy Coverage

E-GUIDE Bringing a new therapy to market can be an arduous process.  Enabling patient access to newly launched product presents an entirely different set of complexities. Fortunately, a manufacturer can get ahead of potential barriers through a five-point guide that...

Maximizing Program Efficiency in the Midst of a Pandemic

THE CHALLENGE A global biotech company faced what under normal circumstances would be a typical challenge. Their patient support programs existed under four different silos, inhibiting their effectiveness. The previous provider had a number of operational challenges...

Is Your Patient Support Program Keeping Up?

By: David Hilman, Chief Operating Officer Patient Assistance Programs (PAP) have long been a core strategy for biopharmaceutical companies in their quest to provide support for patients in need. However, the market has changed dramatically since the advent of these...
CASE STUDY: Achieve Excellence Through Redesign

CASE STUDY: Achieve Excellence Through Redesign

  Challenge A dermatology manufacturer had several challenges impacting their products and sales team success. Communication to the physician offices and the patients was inadequate where you would expect it to be heightened, for an oral product with numerous...
CASE STUDY: The Power of Integrated Services

CASE STUDY: The Power of Integrated Services

  By developing an integrated patient centric approach, we helped a world-leading growth hormone manufacturer to go from sixth to first in market share. Challenge A fragmented, siloed patient support program managed by numerous vendors that ultimately prohibited...